ARMISTICE CAPITAL, LLC - Q3 2017 holdings

$849 Million is the total value of ARMISTICE CAPITAL, LLC's 65 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 84.7% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$145,713,000
+7.6%
580,000
+3.6%
17.16%
-0.5%
HAIN NewHAIN CELESTIAL GROUP INCcall$37,035,000900,000
+100.0%
4.36%
DECK BuyDECKERS OUTDOOR CORPcall$34,205,000
+25.3%
500,000
+25.0%
4.03%
+15.8%
VNDA SellVANDA PHARMACEUTICALS INC$27,423,000
-18.5%
1,532,000
-25.8%
3.23%
-24.7%
DEPO BuyDEPOMED INC$26,935,000
+3.1%
4,652,000
+91.3%
3.17%
-4.7%
ENR BuyENERGIZER HLDGS INC NEW$24,130,000
+43.6%
524,000
+49.7%
2.84%
+32.7%
CPB BuyCAMPBELL SOUP COcall$23,410,000
-6.5%
500,000
+4.2%
2.76%
-13.5%
REGN BuyREGENERON PHARMACEUTICALS$22,356,000
+3.5%
50,000
+13.6%
2.63%
-4.4%
FRPT BuyFRESHPET INC$22,098,000
-0.1%
1,412,000
+6.0%
2.60%
-7.6%
NOMD BuyNOMAD FOODS LTD$21,680,000
+5.5%
1,488,000
+2.2%
2.55%
-2.4%
AVDL BuyAVADEL PHARMACEUTICALS PLCsponsored adr$17,724,000
+39.7%
1,688,000
+46.8%
2.09%
+29.1%
UTHR NewUNITED THERAPEUTICS CORP DEL$17,579,000150,000
+100.0%
2.07%
INCY NewINCYTE CORP$17,044,000146,000
+100.0%
2.01%
PLYA BuyPLAYA HOTELS & RESORTS NV$16,980,000
+13.7%
1,628,000
+30.2%
2.00%
+5.0%
QRTEA BuyLIBERTY INTERACTIVE CORP$16,499,000
+43.7%
700,000
+49.6%
1.94%
+32.8%
ADMS SellADAMAS PHARMACEUTICALS INC$15,878,000
-21.6%
750,000
-35.2%
1.87%
-27.5%
SHPG NewSHIRE PLCcall$15,314,000100,000
+100.0%
1.80%
CPB NewCAMPBELL SOUP CO$13,859,000296,000
+100.0%
1.63%
CAKE NewCHEESECAKE FACTORY INC$13,647,000324,000
+100.0%
1.61%
ATRS SellANTARES PHARMA INC$13,608,000
-25.9%
4,200,000
-26.3%
1.60%
-31.5%
CERC BuyCERECOR INC$13,602,000
+601.5%
16,000,000
+372.8%
1.60%
+548.6%
DKS NewDICKS SPORTING GOODS INC$13,505,000500,000
+100.0%
1.59%
TLRDQ BuyTAILORED BRANDS INC$13,458,000
+703.9%
932,000
+521.3%
1.58%
+644.1%
NVLNF BuyNOVELION THERAPEUTICS INC$13,048,000
-23.7%
1,856,000
+0.2%
1.54%
-29.5%
TPX NewTEMPUR SEALY INTL INCcall$12,904,000200,000
+100.0%
1.52%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$11,693,000
-3.3%
1,694,600
+0.2%
1.38%
-10.7%
SAM NewBOSTON BEER INCcl a$10,934,00070,000
+100.0%
1.29%
PCRX NewPACIRA PHARMACEUTICALS INC$10,814,000288,000
+100.0%
1.27%
COH NewCOACH INC$10,473,000260,000
+100.0%
1.23%
PII SellPOLARIS INDS INC$10,463,000
-47.5%
100,000
-53.7%
1.23%
-51.4%
HBI SellHANESBRANDS INC$10,447,000
-24.8%
424,000
-29.3%
1.23%
-30.5%
IRBT NewIROBOT CORP$10,172,000132,000
+100.0%
1.20%
HZNP SellHORIZON PHARMA PLC$10,144,000
+4.2%
800,000
-2.4%
1.20%
-3.6%
ANF SellABERCROMBIE & FITCH COcl a$10,108,000
-9.7%
700,000
-22.2%
1.19%
-16.5%
MDGL SellMADRIGAL PHARMACEUTICALS INC$9,536,000
+108.0%
212,000
-24.8%
1.12%
+92.3%
OPHT BuyOPHTHOTECH CORP$9,486,000
+54.4%
3,364,000
+40.2%
1.12%
+42.7%
SellPERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0$9,161,000
+29.9%
21,760,000
-4.4%
1.08%
+20.0%
BJRI BuyBJS RESTAURANTS INC$9,135,000
+127.1%
300,000
+177.8%
1.08%
+109.7%
ALIM BuyALIMERA SCIENCES INC$8,456,000
+3.1%
6,264,000
+6.2%
1.00%
-4.7%
FTDCQ BuyFTD COS INC$8,137,000
-22.9%
624,000
+18.2%
0.96%
-28.8%
TTSH NewTILE SHOP HLDGS INC$8,026,000632,000
+100.0%
0.94%
ZGNX NewZOGENIX INCput$7,010,000200,000
+100.0%
0.83%
ETSY NewETSY INC$6,752,000400,000
+100.0%
0.80%
SEAS NewSEAWORLD ENTMT INCcall$6,495,000500,000
+100.0%
0.76%
PAG NewPENSKE AUTOMOTIVE GRP INC$5,899,000124,000
+100.0%
0.70%
BETR NewAMPLIFY SNACK BRANDS$5,785,000816,000
+100.0%
0.68%
NTRI  NUTRI SYS INC NEW$5,590,000
+7.4%
100,0000.0%0.66%
-0.8%
BLUE BuyBLUEBIRD BIO INC$5,219,000
+77.5%
38,000
+35.7%
0.62%
+64.0%
ENTA SellENANTA PHARMACEUTICALS INC$5,054,000
-46.8%
108,000
-59.1%
0.60%
-50.9%
ACHN NewACHILLION PHARMACEUTICALS IN$4,580,0001,020,000
+100.0%
0.54%
SFM NewSPROUTS FMRS MKT INC$4,430,000236,000
+100.0%
0.52%
TSN SellTYSON FOODS INCcl a$3,523,000
-64.8%
50,000
-68.8%
0.42%
-67.5%
PIR NewPIER 1 IMPORTS INC$3,520,000840,000
+100.0%
0.42%
EGLTQ NewEGALET CORP$2,624,0002,050,000
+100.0%
0.31%
ATNM NewACTINIUM PHARMACEUTICALS INC$2,520,0004,382,000
+100.0%
0.30%
APRI NewAPRICUS BIOSCIENCES INC$2,480,0001,450,000
+100.0%
0.29%
MNTA SellMOMENTA PHARMACEUTICALS INC$2,442,000
-82.4%
132,000
-83.9%
0.29%
-83.7%
EYEG  EYEGATE PHARMACEUTICALS INC$1,891,000
-14.6%
1,616,0000.0%0.22%
-20.9%
ATEC BuyALPHATEC HOLDINGS INC$1,488,000
+50.0%
658,414
+22.7%
0.18%
+38.9%
ZFGN NewZAFGEN INC$1,338,000380,000
+100.0%
0.16%
DYNT BuyDYNATRONICS CORP$1,154,000
-17.6%
510,120
+2.0%
0.14%
-23.6%
AVIR BuyAVIRAGEN THERAPEUTICS INC$944,000
+25.5%
1,378,463
+22.8%
0.11%
+15.6%
RTTR NewRITTER PHARMACEUTICALS INC$665,0001,900,000
+100.0%
0.08%
ADMS NewADAMAS PHARMACEUTICALS INCcall$550,00026,000
+100.0%
0.06%
OPGN NewOPGEN INC$144,000464,195
+100.0%
0.02%
JILL ExitJ JILL INC$0-132,000
-100.0%
-0.21%
AVXS ExitAVEXIS INC$0-36,000
-100.0%
-0.38%
OSTK ExitOVERSTOCK COM INC DEL$0-184,000
-100.0%
-0.38%
SFS ExitSMART & FINAL STORES INC$0-364,000
-100.0%
-0.42%
BURL ExitBURLINGTON STORES INC$0-36,000
-100.0%
-0.42%
AVEO ExitAVEO PHARMACEUTICALS INC$0-1,600,000
-100.0%
-0.45%
ANF ExitABERCROMBIE & FITCH COcall$0-500,000
-100.0%
-0.79%
PINC ExitPREMIER INCcl a$0-182,000
-100.0%
-0.84%
CRI ExitCARTER INC$0-78,000
-100.0%
-0.88%
JCPNQ ExitPENNEY J C INC$0-1,800,000
-100.0%
-1.07%
SGYPQ ExitSYNERGY PHARMACEUTICALS DEL$0-2,000,000
-100.0%
-1.13%
LOCO ExitEL POLLO LOCO HLDGS INC$0-700,000
-100.0%
-1.24%
AET ExitAETNA INC NEW$0-64,000
-100.0%
-1.24%
DG ExitDOLLAR GEN CORP NEW$0-140,000
-100.0%
-1.29%
RXDX ExitIGNYTA INC$0-1,000,000
-100.0%
-1.32%
BBBY ExitBED BATH & BEYOND INC$0-352,000
-100.0%
-1.36%
BBY ExitBEST BUY INC$0-200,000
-100.0%
-1.46%
ALXN ExitALEXION PHARMACEUTICALS INC$0-100,000
-100.0%
-1.55%
GCI ExitGANNETT CO INC$0-1,536,000
-100.0%
-1.71%
SEAS ExitSEAWORLD ENTMT INC$0-1,000,000
-100.0%
-2.07%
TPX ExitTEMPUR SEALY INTL INC$0-350,000
-100.0%
-2.38%
HAIN ExitHAIN CELESTIAL GROUP INC$0-672,000
-100.0%
-3.32%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings